Dr. Sherrill R. Loring, MD

Dr. Loring practices at Shepherd Center in Atlanta, Georgia, part of Shepherd Center.

Dr. Loring's NPI, 1861591588, was assigned on September 21, 2006. Dr. Loring graduated from University of South Carolina School of Medicine in 1982. Dr. Loring holds Georgia license MD025253.

Dr. Loring's primary practice is Shepherd Center, at 2020 Peachtree Rd NW, Atlanta, GA 30309 in Fulton County. The practice phone is (404) 350-7311.

Dr. Loring's primary practice is Shepherd Center in Atlanta, Georgia, part of Shepherd Center. The medical group on file is Shepherd Center. Dmand AI also links Dr. Loring to 1 more medical group, named with a free account. Dr. Loring's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Loring practices. Vendor and product names are available with a free account.

Neurology is Dr. Loring's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Loring's licenses on file in 2 states: Georgia and Florida.

CMS data shows 158 Medicare services from Dr. Loring across 2 procedure codes in 2024, all of them office visits, for 123 Medicare patients. Medicare paid $10,500 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Dr. Loring in 2024. The largest group is under 65, with 56 patients. 63% of them have high cholesterol, and 59% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Loring's median patient age at 55, with 80% women.

In 2024, Dr. Loring wrote 2,230 Medicare Part D claims for 243 patients. 86% of them were for generic drugs. CMS names the drug for 1,985 of them, across 42 drugs with 11 or more claims each, at $3,056,164 in total drug cost. In 2023, CMS named 2,155 claims across 49 drugs.

Dr. Loring accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Loring as offering telehealth.

Dmand AI links 1 paper to Dr. Loring in 2019. Dr. Loring's most frequent co-authors are Daniel S. Bandari, MD, Jeffrey I. Greenstein, MD and Mark Gudesblatt, MD.

CMS Open Payments shows 729 general payments to Dr. Loring from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Sanofi and Genzyme US Companies paid the most, $105,363.

Dr. Loring graduated from University of South Carolina School of Medicine in 1982.